(Q34530084)

2 August 2017

1 reference

title

Genetic factors and treatment of mood disorders (English)

1 reference

2 August 2017

Alda M

1

1 reference

2 August 2017

publication date

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

3

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

318-324

1 reference

Pharmacogenetic response to antidepressants in a multicase family with affective disorder.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Serotonin transporter gene and risk for bipolar affective disorder: an association study in Spanish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Multimarkerhaplotypes within the serotonin transporter gene suggest evidence of an association with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

The neurophysiological meaning of auditory P300 in subtypes of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Outcomes on lithium treatment as a tool for genetic studies in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

A family study of bipolar I disorder in adolescence. Early onset of symptoms linked to increased familial loading and lithium resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

A plea for integrity of the bipolar disorder concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Clinical course of affective disorders: were Emil Kraepelin and Jules Angst wrong?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Lithium carbonate treatment of select behavior disorders in children suggesting manic-depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Psychiatric symptoms and syndromes among adolescent children of parents with lithium-responsive or lithium-nonresponsive bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Serotonin transporter gene associated with lithium prophylaxis in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

No association between chromosome-18 markers and lithiumresponsive affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

Pharmacogenetics of antidepressants: clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Differentiation of two genetically specific types of depression by the response to anti-depressants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Mode of inheritance in mood disorder families according to fluvoxamine response

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Serotonin transporter (5-HTT) gene and bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Serotonin transporter gene polymorphism and antidepressant response

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Relationship between the effectiveness of lithium therapy and family history

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Prediction of affective psychoses response to lithium prophylaxis. The role of socio-demographic, clinical, psychological and biological variables

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Who responds to prophylactic lithium?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Lithium response and genetics of affective disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Lithium carbonate prophylaxis failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

"Lithium non-responders" in a lithium clinic

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Relationship between prophylactic effect of lithium therapy and family history of affective disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Family history and symptom levels during treatment for bipolar I affective disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Lithium carbonate use in children and adolescents. A survey of the literature

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Lithium in children of lithium-responding parents

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Evidence for a role of phospholipase C-gamma1 in the pathogenesis of bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

The phospholipase C-gamma1 gene (PLCG1) and lithium-responsive bipolar disorder: re-examination of an intronic dinucleotide repeat polymorphism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Association and linkage studies of CRH and PENK genes in bipolar disorder: a collaborative IGSLI study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30606.X

7 January 2021

10.1034/J.1399-5618.2001.30606.X

Identifiers

DOI

1 reference

2 August 2017

1 reference